Presentation is loading. Please wait.

Presentation is loading. Please wait.

Rigid Bronchoscopic Intervention in Patients with Respiratory Failure Caused by Malignant Central Airway Obstruction  Kyeongman Jeon, MD, Hojoong Kim,

Published byCesare Gigli Modified over 5 years ago

Similar presentations

Presentation on theme: "Rigid Bronchoscopic Intervention in Patients with Respiratory Failure Caused by Malignant Central Airway Obstruction  Kyeongman Jeon, MD, Hojoong Kim,"— Presentation transcript:

1 Rigid Bronchoscopic Intervention in Patients with Respiratory Failure Caused by Malignant Central Airway Obstruction  Kyeongman Jeon, MD, Hojoong Kim, MD, Chang-Min Yu, MD, Won-Jung Koh, MD, Gee Young Suh, MD, Man Pyo Chung, MD, O Jung Kwon, MD  Journal of Thoracic Oncology  Volume 1, Issue 4, Pages (May 2006) DOI: /S (15) Copyright © 2006 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Representative case of malignant central airway obstruction. A, A 70-year-old male patient showed mid-tracheal obstruction on an initial three-dimensional computed tomographic scan. B, Bronchoscopy showed an endotracheal mass almost completely obstructing the lumen. The biopsy identified adenoid cystic carcinoma. C, Because of mediastinal invasion seen on the initial computed tomography, the patient underwent definitive radiotherapy after the emergency bronchoscopic intervention. D, Six months after radiation, follow-up computed tomography showed complete resolution of the tumor. Journal of Thoracic Oncology 2006 1, DOI: ( /S (15) ) Copyright © 2006 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Survival according to etiologic malignancy in patients with central airway obstruction. ACC, adenoid cystic carcinoma; Eso, esophageal cancer; Trac, primary tracheal squamous cell carcinoma; MEC, mucoepidermoid carcinoma; Blad, bladder cancer; HCC, hepatocellular carcinoma; RCC, renal cell carcinoma). Journal of Thoracic Oncology 2006 1, DOI: ( /S (15) ) Copyright © 2006 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Survival according to whether previous or additional definitive therapy had been performed for patients with malignant central airway obstruction. Journal of Thoracic Oncology 2006 1, DOI: ( /S (15) ) Copyright © 2006 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Rigid Bronchoscopic Intervention in Patients with Respiratory Failure Caused by Malignant Central Airway Obstruction  Kyeongman Jeon, MD, Hojoong Kim,"

Similar presentations

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.

Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.
Neoplastic Fever Caused by Lung Cancer

Neoplastic Fever Caused by Lung Cancer
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 

Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 
Primary Mucoepidermoid Carcinoma of the Esophagus

Primary Mucoepidermoid Carcinoma of the Esophagus
Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD  CHEST 

Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD  CHEST 
Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers 

Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers 
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung  Zhigang.

Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung  Zhigang.
David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Incidence of Brain Metastasis at the Initial Diagnosis of Lung Squamous Cell Carcinoma on the Basis of Stage, Excluding Brain Metastasis  Hyun Lee, MD,

Incidence of Brain Metastasis at the Initial Diagnosis of Lung Squamous Cell Carcinoma on the Basis of Stage, Excluding Brain Metastasis  Hyun Lee, MD,
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.

Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
Primary Non-Hodgkin's Lymphoma of the Trachea

Primary Non-Hodgkin's Lymphoma of the Trachea
Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm  Hilâl Tekatli, MD, Saar van ’t Hof, MD, Esther.

Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm  Hilâl Tekatli, MD, Saar van ’t Hof, MD, Esther.

Similar presentations

Ads by Google